Mylan Settles Fortamet Patent Suit With Shionogi, Andrx
Mylan Pharmaceuticals Inc. has settled a patent infringement suit brought by Shionogi Inc. and Andrx Corp. over Mylan's bid to develop a generic equivalent of Shionogi's blood glucose drug Fortamet, Mylan...To view the full article, register now.
Already a subscriber? Click here to view full article